echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Treatment of AIDS is big day sunny enquated he bin for Nofowe film first imitation approved!

    Treatment of AIDS is big day sunny enquated he bin for Nofowe film first imitation approved!

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    June 11th, China Biopharmaceuticals announced that the Group developed the treatment of AIDS drug Entrita-Nofove tablets (commodity name: Keai Ke) has been issued by the State Drug Administration drug registration approval, for the variety of generic drugs in the first domestic approval, and as the same through the consistency evaluationEnquata binte Nofovir tablets are used to treat HIV-1 infection in adults and children over the age of 12 (including) and were originally used as GileadAccording to, Enqual binti Nofovir has global sales of $2.8 billion in 2019.
    The data showed that the Enquati Nofovir tablet contained two active ingredients - Enquatabin and Fumatonove di pisters, both of which were highly effective antiretroviral drugsEnquata binte Nofovir tablets as a single tablet, with simplified treatment, significant efficacy, high patient drug response, low drug resistance and so on, has been included in the 2017 edition of the National Health Insurance Directory.
    Gilead's N'Gotle Stakes Global Sales (MILLIONS) data show that Gilead's N'Tatum-BenfredNovir sales have fallen year-on-year in recent years, from $3.566 billion in 2016 to $2.813 billion in 2019In China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal Enquata Binti Nofowe sales in 2019 46.63 million yuan, an increase of 86.59 percent year-on-year.
    Zhengda Tianqing Pharmaceutical Group Enqutha Binti Nofowei film review timeline up to now, the product also has Qilu Pharmaceutical, Sichuan Haicisco, Anhui Baker Biopharmaceutical imitation 4 categories of listing applications are being reviewed and approved, once approved will be treated as consistent evaluation.
    China Biopharma said that there is no domestic Enta binti Noforwei tablet generic sase on the market, the original research and import products are expensive, greatly increase the cost of drug use for patients, it is difficult to have universalThe approval of this heavy product will expand the clinical drug options for the treatment of HIV-1, reduce the burden of drug use for patients, and have broad market prospects.
    Source: Public Company Announcement, Minnet Database
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.